Table 5.
GCF IL-1β levels | ||||||
---|---|---|---|---|---|---|
Intervention | Mean | SD | Mean | SD | P-value | |
0 to 30 | 111.91 | 74.45 | 65.97 | 48.76 | 0.009** | −45.94 |
30 to 60 | 60.56 | 42.95 | 70.99 | 43.28 | 0.314 | 10.43 |
0 to 60 | 114.14 | 73.68 | 67.49 | 36.53 | 0.002** | −46.65 |
Placebo | ||||||
0 to 30 | 97.83 | 64.72 | 61.48 | 42.93 | 0.007** | −36.35 |
30 to 60 | 67.74 | 48.70 | 67.48 | 37.20 | 0.983 | −0.26 |
0 to 60 | 101.38 | 65.45 | 70.99 | 43.28 | 0.056 | −30.39 |
Intervention |
Placebo |
|||||
Mean | SD | Mean | SD | P-value | ||
0 | 112.20 | 73.17 | 97.83 | 64.72 | 0.424 | |
30 | 65.97 | 48.76 | 61.48 | 42.93 | 0.708 | |
60 | 67.49 | 36.53 | 70.99 | 43.28 | 0.742 | |
0 to 30 | 45.94 | 87.48 | 36.35 | 67.90 | 0.639 | |
30 to 60 | 0.26 | 64.57 | −10.43 | 53.75 | 0.504 | |
0 to 60 | 46.65 | 74.28 | 30.39 | 80.67 | 0.432 |
*P < 0.05 ** P < 0.01.